Marshall Wace, LLP Ac Immune Sa Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Ac Immune Sa stock. As of the latest transaction made, Marshall Wace, LLP holds 99,374 shares of ACIU stock, worth $290,172. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,374

Holding current value

$290,172

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.99 - $4.2 $297,128 - $417,370	99,374 New	99,374 $375,000
Q1 2022 May 16, 2022	SELL	$3.5 - $5.16 $30,992 - $45,691	-8,855 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $239,196 - $374,393	-49,523 Reduced 84.83%	8,855 $44,000
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $78,647 - $105,792	-12,685 Reduced 17.85%	58,378 $391,000
Q2 2021 Aug 13, 2021	BUY	$6.04 - $8.37 $429,220 - $594,797	71,063 New	71,063 $563,000
Q3 2020 Nov 16, 2020	SELL	$4.78 - $9.06 $127,960 - $242,536	-26,770 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$6.57 - $8.3 $311,877 - $394,001	-47,470 Reduced 63.94%	26,770 $181,000
Q1 2020 May 15, 2020	SELL	$4.24 - $9.89 $263,185 - $613,892	-62,072 Reduced 45.54%	74,240 $513,000
Q4 2019 Feb 14, 2020	BUY	$4.56 - $8.78 $443,309 - $853,565	97,217 Added 248.67%	136,312 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$4.8 - $5.89 $92,208 - $113,146	19,210 Added 96.61%	39,095 $193,000
Q2 2019 Aug 14, 2019	SELL	$4.72 - $5.88 $39,940 - $49,756	-8,462 Reduced 29.85%	19,885 $110,000
Q1 2019 May 14, 2019	SELL	$3.65 - $11.68 $2.58 Million - $8.26 Million	-707,555 Reduced 96.15%	28,347 $143,000
Q4 2018 Feb 14, 2019	BUY	$7.35 - $11.7 $5.31 Million - $8.45 Million	722,511 Added 5395.5%	735,902 $6.95 Million
Q3 2018 Nov 14, 2018	BUY	$7.88 - $16.45 $105,521 - $220,281	13,391 New	13,391 $107,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.2M

Call Options Held

150K

Put Options Held

12.4K

Bvf Inc San Francisco, CA

19.5M
Shares

$57 Million
2.35% of portfolio
Black Rock Inc. New York, NY

2.61M
Shares

$7.61 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

1.69M
Shares

$4.95 Million
0.42% of portfolio
Wells Fargo & Company San Francisco, CA

1.11M
Shares

$3.24 Million
0.0% of portfolio
Platinum Investment Management LTD Sydney Australia 2000, C3

952K
Shares

$2.78 Million
0.17% of portfolio

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $244M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account